<?xml version="1.0" encoding="UTF-8"?>
<ref id="B72-antibodies-09-00021">
 <label>72.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jain</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Aresu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Comazzi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Worrall</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Clayton</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Humphries</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Hemmington</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Davis</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Murray</surname>
    <given-names>E.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The development of a recombinant scFv monoclonal antibody targeting canine CD20 for use in comparative medicine</article-title>
  <source>PLoS ONE</source>
  <year>2016</year>
  <volume>11</volume>
  <elocation-id>e0148366</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.pone.0148366</pub-id>
  <pub-id pub-id-type="pmid">26894679</pub-id>
 </element-citation>
</ref>
